pubmed-article:3087182 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:3087182 | lifeskim:mentions | umls-concept:C0035372 | lld:lifeskim |
pubmed-article:3087182 | lifeskim:mentions | umls-concept:C0007806 | lld:lifeskim |
pubmed-article:3087182 | lifeskim:mentions | umls-concept:C0005496 | lld:lifeskim |
pubmed-article:3087182 | lifeskim:mentions | umls-concept:C0870883 | lld:lifeskim |
pubmed-article:3087182 | lifeskim:mentions | umls-concept:C1751431 | lld:lifeskim |
pubmed-article:3087182 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
pubmed-article:3087182 | lifeskim:mentions | umls-concept:C0032744 | lld:lifeskim |
pubmed-article:3087182 | lifeskim:mentions | umls-concept:C0233929 | lld:lifeskim |
pubmed-article:3087182 | pubmed:dateCreated | 1986-6-27 | lld:pubmed |
pubmed-article:3087182 | pubmed:abstractText | We report on the first positron emission tomographic study of dopamine receptor binding in Rett syndrome. The patient is a 25 year old Austrian woman diagnosed at age 2 and followed since then by Rett. A computed axial tomogram (CT scan) showed cortical atrophy, and enlarged ventricles but normal structure of the caudate/putamen. Following the CT scan 20 mCi of 11 C N-methyl spiperone, a butyrophenone with a high affinity for dopamine D2 receptors was administered intravenously. The patient was found to have dopamine D2 receptor binding activity in the low normal range. The caudate/cerebellar activity ratio was below the mean regression line (p = 0.10) that relates the CA/CB ratio as a function of age. Levels of cerebrospinal fluid neurotransmitter metabolites were normal. | lld:pubmed |
pubmed-article:3087182 | pubmed:language | eng | lld:pubmed |
pubmed-article:3087182 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3087182 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:3087182 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3087182 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3087182 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3087182 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3087182 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:3087182 | pubmed:issn | 1040-3787 | lld:pubmed |
pubmed-article:3087182 | pubmed:author | pubmed-author:MoserH WHW | lld:pubmed |
pubmed-article:3087182 | pubmed:author | pubmed-author:NaiduSS | lld:pubmed |
pubmed-article:3087182 | pubmed:author | pubmed-author:WagnerH NHNJr | lld:pubmed |
pubmed-article:3087182 | pubmed:author | pubmed-author:BatshawM LML | lld:pubmed |
pubmed-article:3087182 | pubmed:author | pubmed-author:RettAA | lld:pubmed |
pubmed-article:3087182 | pubmed:author | pubmed-author:HarrisJ CJC | lld:pubmed |
pubmed-article:3087182 | pubmed:author | pubmed-author:LinksJ MJM | lld:pubmed |
pubmed-article:3087182 | pubmed:author | pubmed-author:DannalsR FRF | lld:pubmed |
pubmed-article:3087182 | pubmed:author | pubmed-author:WongD FDF | lld:pubmed |
pubmed-article:3087182 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:3087182 | pubmed:volume | 1 | lld:pubmed |
pubmed-article:3087182 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:3087182 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:3087182 | pubmed:pagination | 201-10 | lld:pubmed |
pubmed-article:3087182 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
pubmed-article:3087182 | pubmed:meshHeading | pubmed-meshheading:3087182-... | lld:pubmed |
pubmed-article:3087182 | pubmed:meshHeading | pubmed-meshheading:3087182-... | lld:pubmed |
pubmed-article:3087182 | pubmed:meshHeading | pubmed-meshheading:3087182-... | lld:pubmed |
pubmed-article:3087182 | pubmed:meshHeading | pubmed-meshheading:3087182-... | lld:pubmed |
pubmed-article:3087182 | pubmed:meshHeading | pubmed-meshheading:3087182-... | lld:pubmed |
pubmed-article:3087182 | pubmed:meshHeading | pubmed-meshheading:3087182-... | lld:pubmed |
pubmed-article:3087182 | pubmed:meshHeading | pubmed-meshheading:3087182-... | lld:pubmed |
pubmed-article:3087182 | pubmed:meshHeading | pubmed-meshheading:3087182-... | lld:pubmed |
pubmed-article:3087182 | pubmed:meshHeading | pubmed-meshheading:3087182-... | lld:pubmed |
pubmed-article:3087182 | pubmed:meshHeading | pubmed-meshheading:3087182-... | lld:pubmed |
pubmed-article:3087182 | pubmed:meshHeading | pubmed-meshheading:3087182-... | lld:pubmed |
pubmed-article:3087182 | pubmed:meshHeading | pubmed-meshheading:3087182-... | lld:pubmed |
pubmed-article:3087182 | pubmed:meshHeading | pubmed-meshheading:3087182-... | lld:pubmed |
pubmed-article:3087182 | pubmed:meshHeading | pubmed-meshheading:3087182-... | lld:pubmed |
pubmed-article:3087182 | pubmed:year | 1986 | lld:pubmed |
pubmed-article:3087182 | pubmed:articleTitle | Positron emission tomographic study of D2 dopamine receptor binding and CSF biogenic amine metabolites in Rett syndrome. | lld:pubmed |
pubmed-article:3087182 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:3087182 | pubmed:publicationType | Case Reports | lld:pubmed |